Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Not Applicable

Recruiting

• Conditions: Breast Cancer; Colorectal Cancer; Ovarian Cancer

• Registration Number: NCT05649072
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

Identifying women at risk for hereditary cancer potentiates prevention, early detection or personalised treatment against cancer. We using mobile mammography units will provide genetic sceening and testing services to underserved women coming for thier mammograms to these units.

Detailed Description

Objectives:

1. To identify underserved women at risk for hereditary breast and colorectal cancers and would be eligible for standard of care genetic counseling and testing using national screening guidelines.

2. To provide education to providers and patients regarding hereditary cancers using previously IRB approved educational material and short video.

Study Timeline

• Study Start: 2022-11-18
• Study First Submitted: 2022-11-23
• Study First Submitted QC: 2022-12-12
• Study First Posted: 2022-12-13
• Status Verified: 2025-06
• Last Update Submitted: 2025-06-03
• Last Update Posted: 2025-06-05
• Primary Completion: 2027-02-02
• Study Completion: 2027-02-02

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 1000

Inclusion Criteria

Any woman scheduled at Project VALET mammography screening mobile units will be eligible for this study.

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
To identify underserved women at risk for hereditary breast and colorectal cancers eligible for standard-of-care genetic counseling using national screening guidelines.	through study completion; an average of 1 year.

Trial Locations

Locations (1)

M D Anderson Cancer Center; 🇺🇸 Houston, Texas, United States